The Ebola outbreak in the Democratic Republic of the Congo, caused by the poorly understood Bundibugyo strain, has expanded to 63 health zones across seven provinces. The WHO confirmed new cases in Bulu, South Ubangi — on the Central African Republic border — and Dungu in Haut-Uele province, bordering South Sudan. Cross-border spread is now an active concern rather than a theoretical one. As of September 23, the DRC has recorded 7,890 confirmed cases and 3,799 deaths, a case fatality rate of 48%. In North Kivu province, the death rate climbs to nearly 60%. These are not abstract statistics: patients in North Kivu's Butembo are avoiding hospitals because they associate treatment centres with death, according to Dr Michel Paluku Mukuloli. By the time many patients arrive, the disease has already reached its most dangerous stage. The contact tracing gap is the number that should alarm policy planners most. Africa CDC Director-General Dr Jean Kaseya estimates that 7,000-plus cases should produce roughly 420,000 contacts requiring monitoring. Health workers have identified just 30,000 — approximately 7%. Kaseya was blunt: 'When the outbreak is at community level, we cannot talk about control.' This is not a system that has fallen slightly behind. It is operating with 93% blindness to potential transmission chains. Conflict is the structural complicator. WHO Director-General Tedros Adhanom Ghebreyesus named displacement and access restrictions as direct impediments to the response. North Kivu and Ituri — the two hardest-hit provinces — are also the epicentres of armed conflict that has displaced millions over the past decade. Responders cannot reach communities they cannot access, and communities that distrust institutions will not voluntarily present for care. The Bundibugyo strain adds a biological layer of difficulty. Unlike the Zaire strain — which responders fought in the 2018-2020 North Kivu outbreak — Bundibugyo has no approved vaccine. The WHO says it is accelerating clinical trials, but 'accelerating' in the middle of an outbreak that has already killed nearly 3,800 people is a euphemism for playing catch-up. Early symptoms mimic malaria and typhoid, meaning cases slip through clinical screening during the very window when treatment is most effective. Ituri province remains the epicentre, accounting for 6,032 of the 7,890 confirmed cases. But North Kivu is gaining share rapidly: it now represents roughly a third of newly confirmed cases and deaths, with 567 new confirmed cases in the last 21 days alone. The outbreak is not centralizing — it is diversifying geographically, the opposite of what a controlled epidemic looks like. The structural picture is grim. No vaccine, conflict-restricted access, a massive contact tracing deficit, community distrust of health facilities, and a virus whose early symptoms are easily mistaken for endemic diseases. Every one of these factors compounds the others. The cross-border spread to regions adjoining CAR and South Sudan raises the prospect that this becomes a multi-country crisis if it is not already.
